CYCLOALKANE CARBOXYLIC ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS

The present invention relates to compounds of formula 1 that are useful for the preventive or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. The invention relates furthermore to a process for the preparation of said compounds, to pharmaceutical compositions cont...

Full description

Saved in:
Bibliographic Details
Main Authors VASAS, Attila, BATORI, Sandor, BATA, Imre, TOMOSOZI, Zsuzsanna, PATEK, Marcel, S. THORPE, David, SZELECZKY, Gabor, FERENCZY, Gyorgy, SMRCINA, Martin, BARTANE BODOR, Veronika, BUZDER-LANTOS, Peter, WEICHSEL, Aleksandra
Format Patent
LanguageEnglish
Published 30.11.2018
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula 1 that are useful for the preventive or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. The invention relates furthermore to a process for the preparation of said compounds, to pharmaceutical compositions containing said compounds and to the novel intermediates used in the preparation of said compounds.
Bibliography:Application Number: MY2014PI01351